Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Venocclusive disease of the liver after allogeneic bone marrow transplantation in man
1988
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
ROS in cancer therapy: the bright side of the moon
2020 Standout
Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia
2001
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Cremophor EL
2001 Standout
Fertility Preservation in Adult Male Cancer Patients
2007
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Vascular disorders of the liver # †
2008 Standout
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Targeting multidrug resistance in cancer
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
2000
Targeting apoptosis in cancer therapy
2020 Standout
Late reproductive sequelae following treatment of childhood cancer andoptions for fertility preservation
2002
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:
2006
Hematopoietic Stem-Cell Transplantation
2006 Standout
Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
2003
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Endocrinological late complications after hematopoietic SCT in children
2008
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma
2005
Endocrine late effects after bone marrow transplant
2002
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:
2004
Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation
1991
Clinical relevance of P-glycoprotein expression in haematological malignancies
1994
Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers
2008
The Impact of Conventional and High-Dose Therapy for Lymphoma on Fertility
2004
Preservation of Fertility in Patients with Cancer
2009 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Antifungal Activities of Antineoplastic Agents:Saccharomyces cerevisiaeas a Model System To Study Drug Action
1999
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study
1996
Mechanisms of Cancer Drug Resistance
2002 Standout
Predominant Hematopoietic Origin of Cell-free DNA in Plasma and Serum after Sex-mismatched Bone Marrow Transplantation
2002
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy
2009
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
2004
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation
1989
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Works of B. Rio being referenced
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey
2001
Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period
1999
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL).
1993
Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
1996
Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy
1986